MiNK Therapeutics Inc. (INKT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MiNK Therapeutics Inc.

    NASDAQ: INKT · Real-Time Price · USD
    15.02
    -0.44 (-2.85%)
    At close: Oct 03, 2025, 3:59 PM
    14.50
    -3.43%
    After-hours: Oct 03, 2025, 07:06 PM EDT

    MiNK Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.42 -1.64 -3.14 -4.94
    PEG Ratio
    		 0.04 0.08 0.39 -0.06
    PS Ratio
    		 n/a n/a 0.03 n/a
    PB Ratio
    		 -1.33 -2.04 -219 6.28
    P/FCF Ratio
    		 -2.73 -2.32 -4.6 -11.42
    P/OCF Ratio
    		 -2.73 -2.33 -4.66 -11.64
    OCF/S Ratio
    		 n/a n/a -0.01 n/a
    Debt / Equity Ratio
    		 -0.25 n/a n/a n/a
    Quick Ratio
    		 0.72 0.32 1.61 2.41
    Current Ratio
    		 0.72 0.32 1.61 2.41
    Asset Turnover
    		 n/a n/a 125.97 n/a
    Interest Coverage
    		 n/a n/a -122.17 -11.66
    Return on Equity
    		 0.55 1.24 69.75 -1.27
    Return on Assets
    		 -1.89 -4.93 -1.3 -0.75
    Return on Invested Capital
    		 8.60 3.35 -3.12 -0.91
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a -10.44 n/a
    Net Profit Margin
    		 n/a n/a -0.01 n/a
    Pretax Profit Margin
    		 n/a n/a -0.01 n/a
    Operating Profit Margin
    		 n/a n/a -0.01 n/a
    FCF Margin
    		 n/a n/a -0.01 n/a
    EBITDA Margin
    		 n/a n/a -0.01 n/a

    Add to Watchlist